Highlights from Las Vegas Exhibition: Ideal Pharma Peptides Secures Major Deals in the US Industry”

Contents

Highlights from Las Vegas Exhibition

Send on email

Ideal Pharma Peptides has harvested a bounty of signed agreements with leaders in the American biological supplements, sports nutrition, and raw materials industries. Key agreements have been reached with companies such as BIOVA, PARAGON LABORATORIES, VITAQWEST, ALASK OMEGA, and others.

These agreements confidently affirm the rapid development and increasing demand for new high-tech peptide raw materials, transitioning from standard raw products to those operating at the human genome level. These products, through bioregulation, allow for the correction of identified deficiencies and pathologies acquired due to environmental influences, stress, and bodily overloads, as well as inefficient nutritional properties.

For researchers

The clinical study’s results of the peptide IPH AGAA properties as a means for the normalization of the system functions of muscles

For health care professionals

Myoprotective Effects of the Peptide IPH AGAA

For public

Classification of Nutritional-Metabolic Support Means in Sports